Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 18;12(8):2485.
doi: 10.3390/nu12082485.

Beneficial Effects of Vitamin K Status on Glycemic Regulation and Diabetes Mellitus: A Mini-Review

Affiliations
Review

Beneficial Effects of Vitamin K Status on Glycemic Regulation and Diabetes Mellitus: A Mini-Review

Hsin-Jung Ho et al. Nutrients. .

Abstract

Type 2 diabetes mellitus is a chronic disease that is characterized by hyperglycemia, insulin resistance, and dysfunctional insulin secretion. Glycemic control remains a crucial contributor to the progression of type 2 diabetes mellitus as well as the prevention or delay in the onset of diabetes-related complications. Vitamin K is a fat-soluble vitamin that plays an important role in the regulation of the glycemic status. Supplementation of vitamin K may reduce the risk of diabetes mellitus and improve insulin sensitivity. This mini-review summarizes the recent insights into the beneficial effects of vitamin K and its possible mechanism of action on insulin sensitivity and glycemic status, thereby suppressing the progression of diabetes mellitus.

Keywords: diabetes mellitus; glycemic status; insulin sensitivity; vitamin K.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

Figures

Figure 1
Figure 1
Vitamin K status of male Wistar rat tissues. Rats were fed a standard AIN-93G rodent diet for three weeks. The levels of vitamin K in tissues were determined using fluorescent high-performance liquid chromatography. MK-4: menaquinone-4. (Reproduced from Ref. [17]).
Figure 2
Figure 2
Schematic illustration of the plausible mechanisms of VK on insulin response and glycemic status. MGP: matrix Gla protein; OC: osteocalcin; TNF-α: tumor necrosis factor α, IL: interleukin.

References

    1. Chaudhury A., Duvoor C., Reddy Dendi V.S., Kraleti S., Chada A., Ravilla R., Marco A., Shekhawat N.S., Montales M.T., Kuriakose K., et al. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Front. Endocrinol. (Lausanne) 2017;8:6. doi: 10.3389/fendo.2017.00006. - DOI - PMC - PubMed
    1. Defronzo R.A. Banting Lecture. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58:773–795. doi: 10.2337/db09-9028. - DOI - PMC - PubMed
    1. Komatsu R., Matsuyama T., Namba M., Watanabe N., Itoh H., Kono N., Tarui S. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide. Diabetes. 1989;38:902–905. doi: 10.2337/diab.38.7.902. - DOI - PubMed
    1. Meier J.J., Nauck M.A., Schmidt W.E., Gallwitz B. Gastric inhibitory polypeptide: The neglected incretin revisited. Regul. Pept. 2002;107:1–13. doi: 10.1016/s0167-0115(02)00039-3. - DOI - PubMed
    1. Vilsbøll T., Krarup T., Madsbad S., Holst J.J. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul. Pept. 2003;114:115–121. doi: 10.1016/s0167-0115(03)00111-3. - DOI - PubMed